Nuvectis Pharma Shares Are Trading Lower. The Company Reported Data From Its Phase 1b Study Evaluating NXP800.
Nuvectis Pharma Shares Are Trading Lower. The Company Reported Data From Its Phase 1b Study Evaluating NXP800.
Nuvectis製藥的股票正在下跌。該公司報告了其10億階段研究評估NXP800的數據。
Nuvectis Pharma Shares Are Trading Lower. The Company Reported Data From Its Phase 1b Study Evaluating NXP800.
Nuvectis製藥的股票正在下跌。該公司報告了其10億階段研究評估NXP800的數據。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間